Abstract
Psoriasis is a chronic inflammatory skin disease and seems to be associated with erectile dysfunction (ED). ED is a predictor of future cardiovascular disease. It is important to identify ED early and investigate cardiovascular problems in psoriasis patients. The sample consisted of 191 psoriasis patients and 191 healthy men. One hundred and one of 191 (52.9%) patients with psoriasis were indicative of ED, compared with 40.3% in control group, reflecting an age-adjusted odds ratio of 1.965 in favor of the psoriasis group. A univariate analysis in the psoriasis group indicated that age, hypertension, hyperlipidemia, diabetes mellitus and depressive symptoms were the risk factors for ED. The multivariate logistic regression model indicated that increasing age, hypertension, hyperlipidemia and depressive symptoms were independent risk factors for ED in psoriasis. The more severe depressive symptoms increased the risk of ED and especially moderate–severe ED. The diagnosis of ED may help prevent emotional and physical discomfort in men and aid in identifying reversible cardiovascular risk factors. Screening of ED may become a part of routine care in the management of psoriasis patients.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Erectile dysfunction and metabolic syndrome components in obese men with psoriasis: response to a 12-week randomized controlled lifestyle modification program (exercise with diet restriction)
Irish Journal of Medical Science (1971 -) Open Access 31 May 2023
-
The psychosocial adaptation of patients with skin disease: a scoping review
BMC Public Health Open Access 29 October 2019
-
Patients’ Perspectives on the Impact of Genital Psoriasis: A Qualitative Study
Dermatology and Therapy Open Access 26 October 2017
Access options
Subscribe to this journal
Receive 8 print issues and online access
$259.00 per year
only $32.38 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout

References
Christophers E . Psoriasis—epidemiology and clinical spectrum. Clin Exp Dermatol 2001; 26: 314–320.
Farber EM, Nall L . Epidemiology: natural history and genetics. In: Roenigk HH, Maibach HI (eds). Psoriasis. Marcel Dekker: New York, NY, USA, 1998, pp 107–157.
Goulding JM, Price CL, Defty CL, Hulangamuwa CS, Bader E, Ahmed I . Erectile dysfunction in patients with psoriasis: increased prevalence, an unmet need, and a chance to intervene. Br J Dermatol 2011; 164: 103–109.
Meeuwis KA, de Hullu JA, van de Nieuwenhof HP, Evers AW, Massuger LF, van de Kerkhof PC et al. Quality of life and sexual health in patients with genital psoriasis. Br J Dermatol 2011; 164: 1247–1255.
Chung SD, Keller JJ, Chu TW, Lin HC . Psoriasis and the risk of erectile dysfunction: a population-based case-control study. J Sex Med 2012; 9: 130–135.
Cabete J, Torres T, Vilarinho T, Ferreira A, Selores M . Erectile dysfunction in psoriasis patients. Eur J Dermatol 2014; 24: 482–486.
Molina-Leyva A, Jimenez-Moleon JJ, Naranjo-Sintes R, Ruiz-Carrascosa JC . Sexual dysfunction in psoriasis: a systematic review. J Eur Acad Dermatol Venereol 2015; 29: 649–655.
Tasliyurt T, Bilir Y, Sahin S, Seckin HY, Kaya SU, Sivgin H et al. Erectile dysfunction in patients with psoriasis: potential impact of the metabolic syndrome. Eur Rev Med Pharmacol Sci 2014; 18: 581–586.
Thompson IM, Tangen CM, Goodman PJ, Probstfield JL, Moinpour CM, Coltman CA . Erectile dysfunction and subsequent cardiovascular disease. JAMA 2005; 294: 2996–3002.
Hare DL, Toukhsati SR, Johansson P, Jaarsma T . Depression and cardiovascular disease: a clinical review. Eur Heart J 2014; 35: 1365–1372.
Miner M, Nehra A, Jackson G, Bhasin S, Billups K, Burnett AL et al. All men with vasculogenic erectile dysfunction require a cardiovascular workup. Am J Med 2014; 127: 174–182.
Yamada T HK, Umematsu H, Suzuki R, Kadowaki T . Erectile dysfunction and cardiovascular events in diabetic men: a meta-analysis of observational studies. PLoS One 2012; 7: e43673.
Vlachopoulos CV, Terentes-Printzios DG, Ioakeimidis NK, Aznaouridis KA, Stefanadis CI . Prediction of cardiovascular events and all-cause mortality with erectile dysfunction: a systematic review and meta-analysis of cohort studies. Circ Cardiovasc Qual Outcomes 2013; 6: 99–109.
Watts GF, Chew KK, Stuckey BG . The erectile-endothelial dysfunction nexus: new opportunities for cardiovascular risk prevention. Nat Clin Pract Cardiovasc Med 2007; 4: 263–273.
Rosen RC, Cappelleri JC, Smith MD, Lipsky J, Pena BM . Development and evaluation of an abridged, 5-item version of the International Index of Erectile Function (IIEF-5) as a diagnostic tool for erectile dysfunction. Int J Impot Res 1999; 11: 319–326.
Radloff LS . The CES-D scale: a self-report depression scale for research in the general population. Appl Psychol Meas 1977; 3: 385–401.
Cho MJ, Nam JJ, Suh GH . Prevalence of symptoms of depression in a nationwide sample of Korean adults. Psychiatry Res 1998; 81: 341–352.
Gelfand JM, Neimann AL, Shin DB, Wang X, Margolis DJ, Troxel AB . Risk of myocardial infarction in patients with psoriasis. JAMA 2006; 296: 1735–1741.
Neimann AL, Shin DB, Wang X, Margolis DJ, Troxel AB, Gelfand JM . Prevalence of cardiovascular risk factors in patients with psoriasis. J Am Acad Dermatol 2006; 55: 829–835.
Miller IM, Ellervik C, Yazdanyar S, Jemec GB . Meta-analysis of psoriasis, cardiovascular disease, and associated risk factors. J Am Acad Dermatol 2013; 69: 1014–1024.
Sterry W, Strober BE, Menter A, International Psoriasis C. Obesity in psoriasis: the metabolic, clinical and therapeutic implications. Report of an interdisciplinary conference and review. Br J Dermatol 2007; 157: 649–655.
Herron MD, Hinckley M, Hoffman MS, Papenfuss J, Hansen CB, Callis KP et al. Impact of obesity and smoking on psoriasis presentation and management. Arch Dermatol 2005; 141: 1527–1534.
Zhang C, Zhu KJ, Zheng HF, Cui Y, Zhou FS, Chen YL et al. The effect of overweight and obesity on psoriasis patients in Chinese Han population: a hospital-based study. J Eur Acad Dermatol Venereol 2011; 25: 87–91.
Armstrong AW, Harskamp CT, Armstrong EJ . Psoriasis and the risk of diabetes mellitus: a systematic review and meta-analysis. JAMA Dermatol 2013; 149: 84–91.
Gisondi P, Tessari G, Conti A, Piaserico S, Schianchi S, Peserico A et al. Prevalence of metabolic syndrome in patients with psoriasis: a hospital-based case-control study. Br J Dermatol 2007; 157: 68–73.
Sampogna F, Gisondi P, Tabolli S, Abeni D, IDIMPRoVE investigators. Impairment of sexual life in patients with psoriasis. Dermatology 2007; 214: 144–150.
Chen YJ, Chen CC, Lin MW, Chen TJ, Li CY, Hwang CY et al. Increased risk of sexual dysfunction in male patients with psoriasis: a nationwide population-based follow-up study. J Sex Med 2013; 10: 1212–1218.
Meuleman EJ, Diemont WL . Investigation of erectile dysfunction. Diagnostic testing for vascular factors in erectile dysfunction. Urol Clin North Am 1995; 22: 803–819.
Kimball AB, Guerin A, Latremouille-Viau D, Yu AP, Gupta S, Bao Y et al. Coronary heart disease and stroke risk in patients with psoriasis: retrospective analysis. Am J Med 2010; 123: 350–357.
Bhutani T, Patel T, Koo B, Nguyen T, Hong J, Koo J . A prospective, interventional assessment of psoriasis quality of life using a nonskin-specific validated instrument that allows comparison with other major medical conditions. J Am Acad Dermatol 2013; 69: e79–e88.
Hackett G, Kell P, Ralph D, Dean J, Price D, Speakman M et al. British Society for Sexual Medicine guidelines on the management of erectile dysfunction. J Sex Med 2008; 5: 1841–1865.
Jackson G, Rosen RC, Kloner RA, Kostis JB . The second Princeton consensus on sexual dysfunction and cardiac risk: new guidelines for sexual medicine. J Sex Med 2006; 3: 28–36, discussion 36.
Jackson G, Boon N, Eardley I, Kirby M, Dean J, Hackett G et al. Erectile dysfunction and coronary artery disease prediction: evidence-based guidance and consensus. Int J Clin Pract 2010; 64: 848–857.
Atlantis E, Sullivan T . Bidirectional association between depression and sexual dysfunction: a systematic review and meta-analysis. J Sex Med 2012; 9: 1497–1507.
Bandini E, Fisher AD, Corona G, Ricca V, Monami M, Boddi V et al. Severe depressive symptoms and cardiovascular risk in subjects with erectile dysfunction. J Sex Med 2010; 7: 3477–3486.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Rights and permissions
About this article
Cite this article
Ji, S., Zang, Z., Ma, H. et al. Erectile dysfunction in patients with plaque psoriasis: the relation of depression and cardiovascular factors. Int J Impot Res 28, 96–100 (2016). https://doi.org/10.1038/ijir.2016.6
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/ijir.2016.6
This article is cited by
-
Erectile dysfunction and metabolic syndrome components in obese men with psoriasis: response to a 12-week randomized controlled lifestyle modification program (exercise with diet restriction)
Irish Journal of Medical Science (1971 -) (2023)
-
The psychosocial adaptation of patients with skin disease: a scoping review
BMC Public Health (2019)
-
High prevalence of erectile dysfunction in men with psoriasis: evidence from a systematic review and meta-analysis
International Journal of Impotence Research (2019)
-
Patients’ Perspectives on the Impact of Genital Psoriasis: A Qualitative Study
Dermatology and Therapy (2017)
-
Psoriasispatienten auf erektile Dysfunktion screenen?
MMW - Fortschritte der Medizin (2016)